Aptus Capital Advisors’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$160M Buy
6,342,898
+113,849
+2% +$2.9M 1.35% 13
2025
Q4
$159M Buy
6,229,049
+1,616,655
+35% +$41.4M 1.35% 16
2025
Q3
$118M Buy
4,612,394
+350,838
+8% +$8.9M 1.08% 28
2025
Q2
$108M Buy
4,261,556
+257,121
+6% +$6.38M 1.06% 27
2025
Q1
$100M Buy
4,004,435
+444,555
+12% +$11M 1.13% 23
2024
Q4
$87.5M Buy
3,559,880
+1,438,262
+68% +$36M 1.04% 27
2024
Q3
$54.5M Buy
2,121,618
+584,472
+38% +$14.8M 0.83% 28
2024
Q2
$37.8M Buy
1,537,146
+385,104
+33% +$9.41M 0.72% 32
2024
Q1
$28.6M Buy
1,152,042
+567,736
+97% +$14.1M 0.61% 42
2023
Q4
$14.7M Sell
584,306
-813,513
-58% -$19.4M 0.44% 61
2023
Q3
$32.8M Buy
1,397,819
+13,687
+1% +$330K 0.96% 26
2023
Q2
$34.1M Buy
+1,384,132
New +$34.3M 1% 28

Other funds holding IBDX